
|Videos|November 13, 2020
AAO 2020: Genentech provides update on presentations, product portfolio
Author(s)OT Staff Reports
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.
Advertisement
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of some of the company’s podium presentations from the Port Delivery System with ranibizumab to the novel pipeline molecule, faricimab.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Corza Medical announces launch of the SensorTek ROP Kit
2
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
3
EyePoint receives second consecutive positive recommendation from DSMC
4
FLORetina Congress celebrates 10 years with joint World Retinopathy of Prematurity meeting
5















































